Get the Stockscreener App
117.73
0.07%
0.08
After Hours:
117.72
-0.01
-0.01%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Abbott Laboratories Stock (ABT) Forecast
The Abbott Laboratories (ABT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $115.50, representing a -1.90% decrease from the current price of $117.73. The highest analyst price target is $117.32, and the lowest is $113.67.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ABT Price Target
Average 120.48
(+2.34% Upside)
Is Abbott Laboratories (ABT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 56.91 | Neutral |
| STOCH(9,6) | 42.33 | Neutral |
| STOCHRSI(14) | 56.27 | Neutral |
| MACD(12,26) | 0.5248 | Buy |
| ADX(14) | 24.07 | Neutral |
| William %R | -35.19 | Neutral |
| CCI(14) | 43.65 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
115.70
Buy
|
116.27
Buy
|
| MA20 |
116.31
Buy
|
115.88
Buy
|
| MA50 |
115.12
Buy
|
114.45
Buy
|
| MA100 |
110.74
Buy
|
112.39
Buy
|
| MA200 |
110.60
Buy
|
109.86
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, ABT could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 0 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on ABT, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 56.91 indicates that ABT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 42.33 indicates that ABT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 56.27 indicates that ABT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.07 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 43.65 indicates that ABT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ABT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Abbott Laboratories financial reports and earnings history, Abbott Laboratories (ABT) stock could reach $143.28 by 2030, $230.82 by 2040 and $306.43 by 2050. See the projected annual prices until 2050 of the Abbott Laboratories stock below:
- Abbott Laboratories (ABT) is expected to reach an average price of $184.44 in 2035, with a high prediction of $184.79 and a low estimate of $172.89. This indicates an $56.66% rise from the last recorded price of $117.73.
- Abbott Laboratories (ABT) stock is projected to chart a bullish course in 2040, with an average price target of $228.71, representing an $94.27% surge from its current level. The forecast ranges from a conservative $217.92 to a sky-high $230.82.
- Our analysts predict Abbott Laboratories (ABT) to jump 115.85% by 2045, soaring from $248.84 to an average price of $254.12, potentially reaching $261.51. While $248.84 is the low estimate, the potential upside is significant.
- Abbott Laboratories (ABT) stock is expected to climb by 2050, reaching an average of $306.21, a $160.10% jump from its current level. However, a wide range of estimates exists, with high and low targets of $306.43 and $297.44, respectively, highlighting the market's uncertainty.
Abbott Laboratories Stock (ABT) Year by Year Forecast
Abbott Laboratories Stock (ABT) Price Forecast for 2024
Our forecast for ABT stock price in 2024 now indicates an average price target of $112.94 with a high forecast of $121.64 and a low forecast of $104.25. The average prediction reflects an decrease of -4.06% from the last recorded price of $117.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $116.98 | $113.67 | $117.32 | -0.64% |
Abbott Laboratories Stock (ABT) Price Forecast for 2025
Abbott Laboratories Stock (ABT) is expected to reach an average price of $120.48 in 2025, with a high prediction of $147.28 and a low estimate of $93.69. This indicates an +2.34% rise from the last recorded price of $117.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $117.59 | $115.20 | $120.71 | -0.12% |
| February, 2025 | $118.91 | $115.70 | $124.16 | +1.01% |
| March, 2025 | $107.21 | $105.93 | $121.84 | -8.93% |
| April, 2025 | $111.45 | $93.69 | $116.52 | -5.34% |
| May, 2025 | $130.54 | $107.53 | $132.24 | +10.88% |
| June, 2025 | $122.33 | $121.11 | $129.12 | +3.91% |
| July, 2025 | $123.32 | $119.54 | $128.00 | +4.75% |
| August, 2025 | $125.82 | $118.84 | $127.68 | +6.87% |
| September, 2025 | $134.21 | $124.55 | $135.81 | +14.00% |
| October, 2025 | $137.33 | $131.67 | $147.28 | +16.65% |
| November, 2025 | $142.13 | $133.64 | $142.81 | +20.72% |
| December, 2025 | $138.63 | $136.66 | $145.02 | +17.75% |
Abbott Laboratories Stock (ABT) Price Forecast for 2026
The predicted value for Abbott Laboratories (ABT) in 2026 is set at an average of $152.19. Estimates vary from a peak of $165.24 to a trough of $139.13, indicating an +29.27% surge from the present price of $117.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $141.31 | $139.32 | $148.71 | +20.03% |
| February, 2026 | $142.82 | $139.13 | $143.46 | +21.31% |
| March, 2026 | $145.32 | $139.26 | $146.91 | +23.43% |
| April, 2026 | $157.24 | $144.31 | $162.71 | +33.56% |
| May, 2026 | $154.62 | $149.03 | $157.43 | +31.34% |
| June, 2026 | $155.30 | $151.65 | $157.19 | +31.91% |
| July, 2026 | $153.03 | $150.99 | $160.04 | +29.98% |
| August, 2026 | $144.78 | $140.22 | $154.06 | +22.97% |
| September, 2026 | $154.85 | $144.57 | $155.34 | +31.53% |
| October, 2026 | $157.42 | $151.41 | $157.91 | +33.71% |
| November, 2026 | $161.74 | $156.30 | $162.68 | +37.38% |
| December, 2026 | $153.74 | $153.59 | $165.24 | +30.59% |
Abbott Laboratories Stock (ABT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Abbott Laboratories (ABT) is $158.71, with a high forecast of $178.83 and a low forecast of $138.60. This indicates an +34.81% increase from the last price of $117.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $162.53 | $150.10 | $162.63 | +38.05% |
| February, 2027 | $162.79 | $159.72 | $167.55 | +38.27% |
| March, 2027 | $173.26 | $159.21 | $175.42 | +47.17% |
| April, 2027 | $164.47 | $163.33 | $178.83 | +39.70% |
| May, 2027 | $166.18 | $155.39 | $167.41 | +41.15% |
| June, 2027 | $158.08 | $151.02 | $167.30 | +34.28% |
| July, 2027 | $155.19 | $150.59 | $159.89 | +31.82% |
| August, 2027 | $156.63 | $152.53 | $161.34 | +33.05% |
| September, 2027 | $153.89 | $141.75 | $157.35 | +30.71% |
| October, 2027 | $139.86 | $138.60 | $155.55 | +18.80% |
| November, 2027 | $146.78 | $140.69 | $147.95 | +24.67% |
| December, 2027 | $149.20 | $141.32 | $149.85 | +26.73% |
Abbott Laboratories Stock (ABT) Price Forecast for 2028
In 2028, Abbott Laboratories (ABT) is projected to reach an average price of $142.92, with a high projection of $154.42 and a low estimate of $131.41. This indicates an +21.39% rise from the last price of $117.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $140.38 | $139.05 | $150.29 | +19.24% |
| February, 2028 | $134.80 | $134.71 | $147.63 | +14.50% |
| March, 2028 | $137.18 | $131.41 | $144.83 | +16.52% |
| April, 2028 | $145.37 | $133.63 | $145.75 | +23.47% |
| May, 2028 | $146.79 | $141.66 | $151.48 | +24.68% |
| June, 2028 | $151.59 | $146.03 | $154.42 | +28.76% |
| July, 2028 | $147.09 | $146.44 | $153.51 | +24.94% |
| August, 2028 | $136.09 | $135.69 | $148.11 | +15.60% |
| September, 2028 | $144.22 | $135.56 | $144.84 | +22.50% |
| October, 2028 | $150.71 | $141.13 | $152.40 | +28.02% |
| November, 2028 | $143.86 | $140.00 | $151.08 | +22.19% |
| December, 2028 | $148.84 | $140.24 | $149.16 | +26.42% |
Abbott Laboratories Stock (ABT) Price Forecast for 2029
The 2029 price forecast for Abbott Laboratories Stock (ABT) is $146.66 on average, with a high prediction of $163.15 and a low estimate of $130.18. This represents an +24.58% increase from the previous price of $117.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $151.35 | $145.90 | $155.81 | +28.56% |
| February, 2029 | $144.39 | $143.42 | $151.31 | +22.64% |
| March, 2029 | $142.08 | $140.07 | $145.44 | +20.68% |
| April, 2029 | $131.37 | $130.18 | $142.45 | +11.59% |
| May, 2029 | $134.67 | $131.41 | $138.73 | +14.39% |
| June, 2029 | $145.75 | $135.24 | $145.85 | +23.80% |
| July, 2029 | $151.10 | $144.79 | $151.76 | +28.34% |
| August, 2029 | $154.38 | $150.36 | $156.83 | +31.13% |
| September, 2029 | $160.85 | $151.93 | $161.54 | +36.63% |
| October, 2029 | $152.16 | $152.13 | $163.15 | +29.25% |
| November, 2029 | $149.03 | $146.00 | $155.65 | +26.59% |
| December, 2029 | $136.35 | $134.67 | $150.02 | +15.82% |
Abbott Laboratories Stock (ABT) Price Forecast for 2030
Abbott Laboratories Stock (ABT) is expected to reach an average price of $140.82 in 2030, with a high forecast of $155.88 and a low forecast of $125.76. This signifies an +19.61% surge from the last price of $117.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $142.80 | $134.74 | $143.28 | +21.30% |
| February, 2030 | $144.75 | $142.27 | $146.84 | +22.95% |
| March, 2030 | $147.03 | $143.83 | $149.82 | +24.89% |
| April, 2030 | $146.59 | $142.85 | $148.43 | +24.51% |
| May, 2030 | $145.53 | $142.67 | $148.08 | +23.62% |
| June, 2030 | $143.92 | $140.74 | $146.74 | +22.25% |
| July, 2030 | $146.32 | $143.36 | $148.52 | +24.29% |
| August, 2030 | $149.95 | $146.09 | $152.18 | +27.37% |
| September, 2030 | $148.58 | $148.44 | $150.88 | +26.20% |
| October, 2030 | $152.87 | $147.38 | $155.88 | +29.85% |
| November, 2030 | $141.43 | $136.00 | $153.68 | +20.13% |
| December, 2030 | $143.18 | $125.76 | $148.63 | +21.62% |
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):